Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Enrofloxacin Hydrochloride
2. 112732-17-9
3. 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic Acid;hydrochloride
4. 93106-59-3
5. Enrofloxacin (hydrochloride)
6. Enrofloxacin (monohydrochloride)
7. Bay Vp 2674 (hydrochloride);pd160788 (hydrochloride)
8. 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
9. Enrofloxacinhcl
10. Schembl16784595
11. Hy-b0502a
12. Dtxsid20920877
13. Mfcd01861684
14. Akos015896571
15. Ac-7615
16. Cs-0009462
17. Ft-0687706
18. 861e684
19. Q-201058
20. 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid--hydrogen Chloride (1/1)
Molecular Weight | 395.9 g/mol |
---|---|
Molecular Formula | C19H23ClFN3O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 395.1411975 g/mol |
Monoisotopic Mass | 395.1411975 g/mol |
Topological Polar Surface Area | 64.1 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 613 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A Enrofloxacin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enrofloxacin Hydrochloride, including repackagers and relabelers. The FDA regulates Enrofloxacin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enrofloxacin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Enrofloxacin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Enrofloxacin Hydrochloride supplier is an individual or a company that provides Enrofloxacin Hydrochloride active pharmaceutical ingredient (API) or Enrofloxacin Hydrochloride finished formulations upon request. The Enrofloxacin Hydrochloride suppliers may include Enrofloxacin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Enrofloxacin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Enrofloxacin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Enrofloxacin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Enrofloxacin Hydrochloride GMP manufacturer or Enrofloxacin Hydrochloride GMP API supplier for your needs.
A Enrofloxacin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Enrofloxacin Hydrochloride's compliance with Enrofloxacin Hydrochloride specifications and serves as a tool for batch-level quality control.
Enrofloxacin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Enrofloxacin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Enrofloxacin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Enrofloxacin Hydrochloride EP), Enrofloxacin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Enrofloxacin Hydrochloride USP).
LOOKING FOR A SUPPLIER?